SR Group, n = 85 | FB Group, n = 86 | P value | |
---|---|---|---|
Approach: | |||
Conventional, n (%) | 60 (70.6) | 59 (65.1) | 0.778 |
Minimally invasive, n (%) | 25 (29.4) | 27 (31.4) | 0.778 |
CPB time, min | 140 (110;179.5) | 160 (122;206) | 0.091 |
Cross clamp time, min: | |||
Conventional | 92 (73;117) | 101 (79;125) | 0.230 |
Minimally invasive | 116 (101;129) | 123 (106;156) | 0.171 |
Mitral valve analyze and intervention in certain patients | |||
А1 prolapse, n (%) | 9 (10.6) | 11 (12.8) | 0.654 |
А2 prolapse, n (%) | 23 (27.1) | 33 (38.4) | 0.115 |
А3 prolapse, n (%) | 13 (15.3) | 19 (22.1) | 0.254 |
P1 prolapse, n (%) | 6 (7.1) | 12 (13.9) | 0.142 |
P2 prolapse, n (%) | 59 (69.4) | 68 (79.1) | 0.119 |
P3 prolapse, n (%) | 17 (20.0) | 27 (31.4) | 0.088 |
AMVL prolapse, n (%) | 31 (36.5) | 40 (46.5) | 0.183 |
PMVL prolapse, n (%) | 73 (85.9) | 74 (86.1) | 0.975 |
DMVL prolapse, n (%) | 19 (22.4) | 28 (32.5) | 0.135 |
Chordae rupture, n (%) | 64 (75.3) | 53 (61.6) | 0.055 |
AMVL resection, n (%) | 1 (1.2) | 4 (4.7) | 0.178 |
PMVL resection, n (%) | 37 (43.5) | 49 (56.9) | 0.079 |
AMVL neochordae, n (%) | 22 (25.9) | 29 (33.7) | 0.263 |
PMVL neochordae, n (%) | 30 (35.3) | 27 (31.4) | 0.589 |
Ring size, mm | 32 (30;32) | 34 (30;34) | 0.456 |
Concomitant procedure | |||
Maze IV procedure, n (%) | 18 (21.2) | 14 (16.3) | 0.412 |
CABG, n (%) | 10 (11.8) | 4 (4.7) | 0.090 |
TV repair, n (%) | 32 (37.6) | 24 (27.9) | 0.175 |
SAM-syndrome, n (%) | 0 | 1 (1.2) | 0.319 |
Intraoperative TEE | |||
Depth of coaptation, mm | 9 (7;11) | 6 (5;8) | 0.006 |
Peak MV gradient, mm Hg | 8.0 (6.7;10.9) | 6.4 (4;9) | <0.001 |
Mean MV gradient, mm Hg | 3 (2.4;4) | 2 (2;3.9) | <0.001 |